JPRN-UMIN000006626招募中未知
Evaluation of KRAS and BRAF mutation rate in cholangiocarcinoma - Evaluation of KRAS and BRAF mutation rate in cholangiocarcinoma
Division of Hepato-Biliary Pancreatic Surgery , Tohoku University Hospital0 个研究点目标入组 300 人开始时间: 2011年10月28日最近更新:
适应症
试验速览
- 阶段
- 未知
- 状态
- 招募中
- 发起方
- 入组人数
- 300
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •All patients who does not meet the key inclusion criteria above.
研究者
相似试验
已完成
不适用
Effects of mutations in KRAS and BRAF gene and histological parameters on the clinical course of disease in patients with metastatic colorectal cancerMetastatic colorectal cancerMalignant neoplasm of colonCancerISRCTN10604174Institute of Oncology Ljubljana (Slovenia)400
尚未招募
不适用
Prevalence of two mutations (KRAS and BRAF) in patients diagnosed with Colorectal Cancer.CTRI/2013/09/004023Dr Prachi S Patil200
招募中
不适用
Investigation of the BRAF mutation status in the pleural punctate in patients with malignant melanoma, colorectal or lung cancer, that show a BRAF mutation in the primary tumor and the comparison of the result with the conventional cytological / immunohistochemical and molecular cytology findings of the pleural punctateC43C34C18J90Malignant melanoma of skinMalignant neoplasm of bronchus and lungMalignant neoplasm of colonPleural effusion, not elsewhere classifiedDRKS00017491Onkologiezentrum Donauwörth15
招募中
不适用
Comparative analysis of KRAS and EGFR mutation detection in liquid biopsy vs tissue biopsy in patients with NSCLCNon-small-cell lung carcinoma10038666lung cancerNL-OMON48625Jeroen Bosch Ziekenhuis150
已完成
不适用
A clinical study of relevance to KRAS mutations and acquired resistance to anti-EGFR therapy in colorectal cancerColorectal cancerJPRN-UMIN000013154Department of Medical Oncology, Niigata University Graduate School of Medical and Dental Sciences20